Greg Harris
- Democratic
Amends the Electronic Fund Transfer Act. Makes a technical change in a Section concerning powers and duties under the Act. House Committee Amendment No. 1 Deletes reference to: 205 ILCS 616/20 Adds reference to: New Act 5 ILCS 140/7.5 5 ILCS 375/6.11 215 ILCS 5/Art. XXXIIB heading new 215 ILCS 5/513b1 new 215 ILCS 5/513b2 new 215 ILCS 5/513b3 new 215 ILCS 5/513b4 new 215 ILCS 5/513b5 new 215 ILCS 5/513b6 new 215 ILCS 125/5-3 from Ch. 111 1/2, par. 1411.2 215 ILCS 134/30 215 ILCS 134/65 225 ILCS 85/42 new 305 ILCS 5/5-36 new Replaces everything after the enacting clause. Amends the Illinois Insurance Code. Provides that a contract between a health insurer and a pharmacy benefit manager must:(1) require the pharmacy benefit manager to update maximum allowable cost pricing information and maintain a process that will eliminate drugs from maximum allowable cost lists or modify drug prices to remain consistent with changes in pricing data; (2) prohibit the pharmacy benefit manager from limiting a pharmacist's ability to disclose the availability of a more affordable alternative drug; and (3) prohibit the pharmacy benefit manager from requiring an insured to make a payment for a prescription drug in an amount that exceeds the lesser of the applicable cost-sharing amount or the retail price of the drug. Contains provisions concerning the inclusion of prescription drugs on a maximum allowable cost list, State licensing requirements for pharmacy benefit managers, and other matters. Makes conforming changes to other Acts. Amends the Managed Care Reform and Patient Rights Act. Provides that a health care plan shall apply any third-party payments for prescription drugs. Makes changes to provisions concerning the denial of coverage for emergency services. Amends the Illinois Public Aid Code. Provides that the Department of Healthcare and Family Services may enter into a contract with any third party on a fee-for-service reimbursement model for the purpose of administering pharmacy benefits. Requires the Department to ensure coordination of care between the third-party administrator and managed care organizations as a consideration in any contracts established. Amends the Freedom of Information Act to exempt from disclosure certain information pharmacy benefits managers are required to provide under the Illinois Public Aid Code. Contains a severability provision. House Floor Amendment No. 2 Deletes reference to: 215 ILCS 134/65 Adds reference to: 5 ILCS 140/7 215 ILCS 134/10 Replaces everything after the enacting clause. Reinserts the provisions of House Amendment No. 1, but with the following changes: Further amends the Illinois Insurance Code. In a provision concerning contracts between health insurers and pharmacy benefit managers, provides that such contracts must require pharmacy benefit managers to: (1) update maximum allowable cost pricing information at least every 7 calendar days; (2) provide access to its maximum allowable cost list to each pharmacy or pharmacy services administrative organization, as defined, subject to the maximum allowable cost list; (4) provide a process by which a contracted pharmacy can appeal the provider's reimbursement for a drug subject to maximum allowable cost pricing; and other matters. Regarding a drug on the maximum allowable cost list, requires pharmacy benefits managers to ensure that: (i) if a drug is a generically equivalent drug, it is listed as therapeutically equivalent and pharmaceutically equivalent to certain rating standards; (ii) the drug is available for purchase by each pharmacy in the State from national or regional wholesalers operating in Illinois; and (ii) the drug is not obsolete (rather than requiring a drug to have at least 3 or more nationally available, therapeutically equivalent, multiple source generic drugs with a significant cost difference and be available for purchase without limitations by all pharmacies in the State from national or regional wholesalers). Permits the Director of Insurance to examine a pharmacy benefit manager's designee, representative, or other specified persons (rather than any individual) about the business of the pharmacy benefit manager. Contains provisions concerning the denial of a pharmacy benefits manager's registration application or the suspension or revocation of a pharmacy benefits manager's registration. Defines terms. Further amends the Managed Care Reform and Patient Rights Act. Makes changes to the definition of "emergency medical condition". Removes changes made to a provision concerning the denial of coverage and payment for emergency services provided without prior authorization or an approved plan. Further amends the Illinois Public Aid Code. Makes changes to certain reporting requirements imposed on the Director of Healthcare and Family Services. Requires a pharmacy benefit manager to make certain disclosures to the Department of Healthcare and Family Services upon request. Requires a pharmacy benefit manager to make certain written disclosures to a pharmacy provider or pharmacy services administrative organization. Defines "pharmacy services administrative organization." Requires the Department to adopt rules establishing reasonable dispensing fees for fee-for-service payments in accordance with guidance or guidelines from the federal Centers for Medicare and Medicaid Services.
Public Act . . . . . . . . . 101-0452
Effective Date January 1, 2020
Governor Approved
Sent to the Governor
Added as Alternate Co-Sponsor Sen. Napoleon Harris, III
Passed Both Houses
Third Reading - Passed; 057-000-000
Rule 2-10 Third Reading Deadline Established As May 31, 2019
Added as Alternate Co-Sponsor Sen. Chapin Rose
Added as Alternate Co-Sponsor Sen. Chuck Weaver
Second Reading
Placed on Calendar Order of 3rd Reading May 17, 2019
Added as Alternate Co-Sponsor Sen. Paul Schimpf
Placed on Calendar Order of 2nd Reading May 14, 2019
Added as Alternate Co-Sponsor Sen. Steve McClure
Do Pass Insurance; 018-000-000
Added as Alternate Co-Sponsor Sen. Sue Rezin
Added as Alternate Co-Sponsor Sen. Jennifer Bertino-Tarrant
Added as Alternate Co-Sponsor Sen. Dan McConchie
Added as Alternate Chief Co-Sponsor Sen. Melinda Bush
Added as Alternate Chief Co-Sponsor Sen. Dale Fowler
Added as Alternate Chief Co-Sponsor Sen. Laura M. Murphy
Added as Alternate Chief Co-Sponsor Sen. Linda Holmes
Alternate Chief Sponsor Changed to Sen. Andy Manar
Assigned to Insurance
Placed on Calendar Order of First Reading
Referred to Assignments
First Reading
Chief Senate Sponsor Sen. John J. Cullerton
Arrive in Senate
Placed on Calendar Order of 3rd Reading - Short Debate
House Floor Amendment No. 2 Recommends Be Adopted Prescription Drug Affordability & Accessibility Committee; 011-000-000
Added Co-Sponsor Rep. Keith P. Sommer
Added Co-Sponsor Rep. Carol Ammons
Added Co-Sponsor Rep. Celina Villanueva
Added Co-Sponsor Rep. Delia C. Ramirez
Added Co-Sponsor Rep. Kelly M. Cassidy
Added Co-Sponsor Rep. Anne Stava-Murray
Added Co-Sponsor Rep. Jennifer Gong-Gershowitz
Added Co-Sponsor Rep. Lamont J. Robinson, Jr.
Added Co-Sponsor Rep. Maurice A. West, II
Added Co-Sponsor Rep. Joyce Mason
Added Co-Sponsor Rep. Aaron M. Ortiz
House Floor Amendment No. 2 Adopted
Added Co-Sponsor Rep. Tim Butler
Third Reading - Short Debate - Passed 113-000-001
Held on Calendar Order of Second Reading - Short Debate
Second Reading - Short Debate
House Floor Amendment No. 2 Rules Refers to Prescription Drug Affordability & Accessibility Committee
Added Co-Sponsor Rep. Yehiel M. Kalish
House Floor Amendment No. 2 Referred to Rules Committee
House Floor Amendment No. 2 Filed with Clerk by Rep. Gregory Harris
Added Co-Sponsor Rep. Thomas M. Bennett
Added Co-Sponsor Rep. Kelly M. Burke
Added Chief Co-Sponsor Rep. Elizabeth Hernandez
Added Co-Sponsor Rep. Brad Halbrook
Placed on Calendar 2nd Reading - Short Debate
House Committee Amendment No. 1 Adopted in Prescription Drug Affordability & Accessibility Committee; by Voice Vote
Do Pass as Amended / Short Debate Prescription Drug Affordability & Accessibility Committee; 016-000-000
Added Co-Sponsor Rep. Dave Severin
House Committee Amendment No. 1 Rules Refers to Prescription Drug Affordability & Accessibility Committee
Re-assigned to Prescription Drug Affordability & Accessibility Committee
Added Co-Sponsor Rep. Robyn Gabel
Added Co-Sponsor Rep. Monica Bristow
Added Co-Sponsor Rep. Darren Bailey
Added Chief Co-Sponsor Rep. Anna Moeller
Chief Sponsor Changed to Rep. Gregory Harris
Added Chief Co-Sponsor Rep. C.D. Davidsmeyer
Added Co-Sponsor Rep. Sara Feigenholtz
Added Co-Sponsor Rep. Grant Wehrli
Added Co-Sponsor Rep. Mike Murphy
Added Co-Sponsor Rep. Dan Caulkins
Added Co-Sponsor Rep. Emanuel Chris Welch
Added Co-Sponsor Rep. Jerry Costello, II
Added Co-Sponsor Rep. Jaime M. Andrade, Jr.
Added Co-Sponsor Rep. Michael Halpin
Added Co-Sponsor Rep. Robert Martwick
Added Co-Sponsor Rep. Mark L. Walker
Added Co-Sponsor Rep. Will Guzzardi
Added Co-Sponsor Rep. Martin J. Moylan
Added Co-Sponsor Rep. Ann M. Williams
Added Co-Sponsor Rep. Michael J. Zalewski
House Committee Amendment No. 1 Filed with Clerk by Rep. Gregory Harris
House Committee Amendment No. 1 Referred to Rules Committee
Assigned to Executive Committee
First Reading
Referred to Rules Committee
Filed with the Clerk by Rep. Michael J. Madigan
Bill Text Versions | Format |
---|---|
Introduced | HTML |
Engrossed | HTML |
Enrolled | HTML |
Document | Format |
---|---|
Public Act | |
House Amendment 002 | |
House Amendment 001 |
Data on Open States is updated periodically throughout the day from the official website of the Illinois General Assembly.
If you notice any inconsistencies with these official sources, feel free to file an issue.